kyoto.jpeg

kyoto

kyotovisitorshost.jpeg

kyotovisitorshost

General information

Announcements(0)

Overview

Pre-registration

Abstract Submission (Oral/Poster Presentation)

Guidelines for Writing Abstracts (Oral/Poster Pres

Program

Sessions

Search presentations

pharm140_e.png

icon_20251203154432448.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

VNUT is a therapeutic target for type 2 diabetes and NASH

The human transporter, which has about 5-600 species, is the last research frontier as a drug discovery resource left for humankind. Although many of the technical problems unique to transporters had hindered development, these have already been solved, and a system for measuring the transport function of any transporter and a high-throughput screening system for substances that specifically bind to the transporter are now in practical use.  Thus, it can be said that transporter-targeted drug discovery has finally reached its development stage after a long period of stagnation. In light of this situation, this symposium will provide a scientific basis (software) and transporter analysis of "why transporter inhibitors (activators) become drugs", which is essential in promoting transporter drug discovery.  Recent achievements in both technical progress (hardware) are also presented. We would like to draw a real image of transporter drug discovery and discuss the future image.

Strategies of transporter research for transporter-targeted drug discovery

The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)

Presentation Information

[S09-5]VNUT is a therapeutic target for type 2 diabetes and NASH

Password required to view